Literature DB >> 15982211

Stromal cells in hemangioblastoma: neuroectodermal differentiation and morphological similarities to ependymoma.

Keisuke Ishizawa1, Takashi Komori, Takanori Hirose.   

Abstract

The histogenesis of stromal cells in hemangioblastoma is inconclusive despite a long-term controversy. An immunohistochemical and ultrastructural study was conducted for 17 cases of cerebellar hemangioblastoma. A wide range of immunohistological markers, targeting epithelial, mesenchymal, endothelial and neuroectodermal tissues, was used. In all cases, the microscopic hallmark characterizing hemangioblastomas, that is, lipid-containing stromal cells and a fine capillary network, known as a reticular variant, was noted. Stromal cells showed a variable immunoreactivity for neuroectodermal markers, such as S-100 protein, CD56, CD57, CD99, and neuron-specific enolase. This result, in conjunction with the absence of immunoreactivity for epithelial, mesenchymal, and endothelial markers, likely suggests neuroectodermal differentiation of stromal cells. In three cases, another component, known as a cellular variant, where epithelioid tumor cells were arranged in nests encircled by capillaries and/or in pseudorosette-like structures, was noted. Glial fibrillary acidic protein-immunoreactivity, which was totally absent in cases only showing the reticular pattern, was noted in two of them, suggesting a distinctive sign of glial differentiation in a proportion of hemangioblastomas. Ultrastructurally, microvilli-like projections in intracytoplasmic vacuoles were demonstrated in stromal cells. This result, taken together with the neuroectodermal hypothesis of stromal cells, suggests that hemangioblastomas may occasionally exhibit morphological similarities to ependymomas.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15982211     DOI: 10.1111/j.1440-1827.2005.01841.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  13 in total

1.  CD41 and CD45 expression marks the angioformative initiation of neovascularisation in human haemangioblastoma.

Authors:  Dexuan Ma; Ying Wang; Guhong Du; Jingyun Yang; Qisheng Tang; Liangfu Zhou
Journal:  Tumour Biol       Date:  2015-10-14

2.  VHL-deficient vasculogenesis in hemangioblastoma.

Authors:  Sven Gläsker; Jonathan Smith; Mark Raffeld; Jie Li; Edward H Oldfield; Alexander O Vortmeyer
Journal:  Exp Mol Pathol       Date:  2014-01-04       Impact factor: 3.362

3.  Congenital extraneural hemangioblastoma in a lamb.

Authors:  Turan Yaman; Abdullah Karasu; Ahmet Uyar; Yağmur Kuşçu; Ömer Faruk Keleş
Journal:  J Vet Diagn Invest       Date:  2019-02-17       Impact factor: 1.279

4.  CD99 is upregulated in placenta and astrocytomas with a differential subcellular distribution according to the malignancy stage.

Authors:  Ursula Úrias; Suely K N Marie; Miyuki Uno; Roseli da Silva; Mariá M Evagelinellis; Otavia L Caballero; Brian J Stevenson; Wilson A Silva; Andrew J Simpson; Sueli M Oba-Shinjo
Journal:  J Neurooncol       Date:  2014-05-06       Impact factor: 4.130

Review 5.  Systemic VHL gene functions and the VHL disease.

Authors:  Hannah L Bader; Tien Hsu
Journal:  FEBS Lett       Date:  2012-04-25       Impact factor: 4.124

Review 6.  Central nervous system capillary haemangioblastoma: the pathologist's viewpoint.

Authors:  Mahmoud R Hussein
Journal:  Int J Exp Pathol       Date:  2007-10       Impact factor: 1.925

7.  Differentiation of hemangioblastomas from pilocytic astrocytomas using 3-T magnetic resonance perfusion-weighted imaging and MR spectroscopy.

Authors:  D J She; Z Xing; Z Zeng; X Y Shang; D R Cao
Journal:  Neuroradiology       Date:  2014-12-07       Impact factor: 2.804

8.  Expression of inhibin alpha by stromal cells of retinal angiomas excised from a patient with von Hippel-Lindau disease.

Authors:  Akiko Miyazawa; Makoto Inoue; Akito Hirakata; Annabelle A Okada; Kuniko Iihara; Yasunori Fujioka
Journal:  Jpn J Ophthalmol       Date:  2009-10-22       Impact factor: 2.447

9.  Protracted haemangioblastic proliferation and differentiation in von Hippel-Lindau disease.

Authors:  S B Shively; S Beltaifa; B Gehrs; H Duong; J Smith; N A Edwards; Rr Lonser; M Raffeld; A O Vortmeyer
Journal:  J Pathol       Date:  2008-12       Impact factor: 7.996

10.  Galectin-3: a novel protein in cerebellar hemangioblastoma.

Authors:  Suhail Al-Salam; Mohammed Al-Salam; Moueid Al Ashari
Journal:  Int J Clin Exp Pathol       Date:  2013-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.